The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
Open accessAbstract
Tumour hypoxia is increasingly recognized as a major deleterious factor in cancer therapies, as it compromises treatment and drives malignant progression. This review seeks to clarify the oxygen levels that are pertinent to this issue. It is argued that normoxia (20% oxygen) is an extremely poor comparator for "physoxia", i.e. the much lower levels of oxygen universally found in normal tissues, which averages about 5% oxygen, and ranges from about 3% to 7.4%. Importantly, it should be recognized that the median oxygenation in untreated tumours is significantly much lower, falling between approximately 0.3% and 4.2% oxygen, with most tumours exhibiting median oxygen levels <2%. This is partially dependent on the tissue of origin, and it is notable that many prostate and pancreatic tumours are profoundly hypoxic. In addition, therapy can induce even further, often unrecognized, changes in tumour oxygenation that may vary longitudinally, increasing or decreasing during treatment in ways that are not always predictable. Studies that fail to take cognizance of the actual physiological levels of oxygen in tissues (approximately 5%) and tumours (approximately 1%) may fail to identify the real circumstances driving tumour response to treatment and/or malignant progression. This can be of particular importance in genetic studies in vitro when comparison to human tumours is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced oxygen tension activates a conserved hypoxic signaling network centered on hypoxia-inducible factors (HIFs)”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, both physiological and pathological states can transiently disrupt the equilibrium between oxygen supply and demand, resulting in tissue and cellular hypoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In liver metastases of colorectal cancer, the median PO2 was 6 mmHg as compared with 30 mmHg in normal liver tissue (20).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This response features extensive transcriptional reprogramming aimed at preserving cellular integrity under low-oxygen conditions”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,373
Research works printed but not linked: 8
- Vaupel P, 2010, Exp Oncol, 32, 125
- Vaupel P, 2003, Cancer Res, 63, 7634
- Höckel M, 1991, Cancer Res, 51, 6098
- Kallinowski F, 1995, Tumor oxygenation, 291
- Kallinowski F, 1995, Tumor oxygenation, 205
- Vaupel P, 2006, Eur J Gynaecol Oncol, 27, 142
- Stone JE, 2005, Eur J Gynaecol Oncol, 26, 31
- Cairns RA, 2001, Cancer Res, 61, 8903
Cited by
Sorted by citations
Items 601–700 of 1,000
Inverse correlation between Alzheimer’s disease and cancer from the perspective of hypoxia
Su, Z., Zhang, G., Li, X., & Zhang, H. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.002 · Cited by 7
Zhang, N., Chen, R., Cao, X., & Wang, L. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1458_21 · Cited by 8
Montecchi, T., Nannini, G., Tommaso, D. D., Cassioli, C., Coppola, F., Ringressi, M. N., Carraro, F., Naldini, A., Taddei, A., Marotta, G., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03614-0 · Cited by 7
Image-based biomarkers for engineering neuroblastoma patient-specific computational models
Hervás-Raluy, S., Sainz‐DeMena, D., Gómez‐Benito, M. J., & García‐Aznar, J. M. (2024) · Engineering With Computers · doi:10.1007/s00366-024-01964-6 · Cited by 7
Kumar, P., Lacroix, M., Dupré, P., Arslan, J., Fenou, L., Orsetti, B., Cam, L. L., Racoceanu, D., & Radulescu, O. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad524a · Cited by 7
Characterising Cancer Cell Responses to Cyclic Hypoxia Using Mathematical Modelling
Celora, G. L., Nixson, R., Pitt‐Francis, J., Maini, P. K., & Byrne, H. M. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01359-0 · Cited by 7
Phua, T. J. (2025) · Frontiers in Aging · doi:10.3389/fragi.2024.1526230 · Cited by 8
FOLR1-Targeted Oxygen-Delivering Nanosomes Enhance Chemo-Induced Apoptosis in Hypoxic Cancer
Lee, G., Kim, J., Yang, J., Jang, Y., Jang, J., Tanaka, M., Niepa, T. H. R., Lee, H.-Y., & Choi, J. H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s513688 · Cited by 7
Matsuya, Y., McMahon, S. J., Butterworth, K. T., Naijo, S., Nara, I., Yachi, Y., Saga, R., Ishikawa, M., Sato, T., Date, H., et al. (2021) · Physics in Medicine and Biology · doi:10.1088/1361-6560/abf011 · Cited by 7
Reid, M. A., Sanderson, S. M., & Locasale, J. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00009-8 · Cited by 9
Ajouaou, Y., Azouz, A., Taquin, A., Denanglaire, S., Hussein, H., Krayem, M., Andris, F., Moser, M., Goriely, S., & Léo, O. (2022) · eLife · doi:10.7554/elife.70555 · Cited by 6
Liang, H., Wang, J., Zhou, Y. J., Shang, G., Guo, T., Tang, H., Li, J., Luo, Y., Zeng, X., Zeng, Z., et al. (2023) · Cancers · doi:10.3390/cancers15051576 · Cited by 7
Do We Preserve Tumor Control Probability (TCP) in FLASH Radiotherapy? A Model-Based Analysis
Liew, H., Mein, S., Tessonnier, T., Abdollahi, A., Debus, J., Đokić, I., & Mairani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065118 · Cited by 7
Brazel, A. J., & Graciet, E. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3044-0_2 · Cited by 7
Chow, C. C. T., Kobayashi, M., Kambe, G., & Harada, H. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168162 · Cited by 8
Inflammation-Associated Cytotoxic Agents in Tumorigenesis
Arnhold, J. (2023) · Cancers · doi:10.3390/cancers16010081 · Cited by 7
Induction and Assessment of Hypoxia in Glioblastoma Cells In Vitro
Gagner, J., Lechpammer, M., & Zagzag, D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7659-1_9 · Cited by 7
Hypoxic Physiological Environments in a Gas-Regulated Microfluidic Device
Lee, I., Woo, J. H., Lee, M., Jeon, T., & Kim, S. M. (2018) · Micromachines · doi:10.3390/mi10010016 · Cited by 7
Kawahara, D., Wu, L., & Watanabe, Y. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab7974 · Cited by 7
Down-Regulation of Collagen Hydroxylation in Colorectal Liver Metastasis
van Huizen, N. A., Burgers, P. C., van Rosmalen, J., Doukas, M., IJzermans, J. N. M., & Luider, T. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.557737 · Cited by 7
Zakaria, S., Nawaya, R. A., Abdel‐Hamid, N. M., El-Domany, R. A., & El‐Shishtawy, M. M. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210811121120 · Cited by 7
Kawahara, D., Nagata, Y., & Watanabe, Y. (2021) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ac4466 · Cited by 7
Experimental assessment of robust reference genes for qRT-PCR in lung cancer studies
Gu, W., Wang, Y., Xu, R., Li, J., Jin, J., Zhao, J., Chen, Y., Lu, Y., & Zhang, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1178629 · Cited by 7
Forkan, C. P., Shrestha, A., Yu, A., Chuang, C. Y., Pociot, F., & Yarani, R. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04153-4 · Cited by 6
Carbon ion irradiation mobilizes antitumor immunity: from concept to the clinic
Liu, S., He, X., Liang, S., Wu, A., Liu, L., & Hu, W. (2025) · Radiation Oncology · doi:10.1186/s13014-025-02647-2 · Cited by 7
Exogenous/endogenous stimuli-responsive antitumor prodrugs advance precision chemotherapy
Wang, L., Li, J., Zeng, X., Lu, Q., Wang, Y., Anwar, Z., Li, X., Fan, H., & Sun, H. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118485 · Cited by 6
Discovery of the Hypoxia-Activated Prodrug SN30000
Hay, M. P., Hicks, K. O., & Wilson, W. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12450-3 · Cited by 6
Combined RBE and OER optimization in proton therapy with FLUKA based on EF5‐PET
Henjum, H., Dahle, T. J., Mairani, A., Pilskog, S. M. C., Stokkevåg, C. H., Boer, C. G., Redalen, K. R., Minn, H. R. I., Malinen, E., & Ytre-Hauge, K. S. (2023) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.14014 · Cited by 6
Khemiri, I., Tebbji, F., Burgain, A., & Sellam, A. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae018 · Cited by 6
Chen, N., Li, Y.-W., Cao, S.-J., Zhang, Y., Li, C., Zhou, W., Li, M., Du, Y.-T., Zhang, Y.-X., Xing, M.-W., et al. (2024) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2024.111520 · Cited by 6
Tumor microenvironment-like conditions alter pancreatic cancer cell metabolism and behavior
Gardner, G. L., & Stuart, J. A. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00452.2024 · Cited by 7
Nisar, H., Brauny, M., Labonté, F. M., Schmitz, C., Konda, B., & Hellweg, C. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312590 · Cited by 6
The Biophysics of Flash Radiotherapy: Tools for Measuring Tumor and Normal Tissues Microenvironment
Ali, I. G., & Naqa, I. E. (2025) · Antioxidants · doi:10.3390/antiox14080899 · Cited by 6
Oxygen Depletion in Proton Spot Scanning: A Tool for Exploring the Conditions Needed for FLASH
Rothwell, B., Lowe, M., Kirkby, N. F., Merchant, M. J., Chadwick, A. L., Mackay, R. I., Hendry, J. H., & Kirkby, K. J. (2021) · Radiation · doi:10.3390/radiation1040024 · Cited by 6
Filho, C., Glinos, A. T., Jang, Y., Goloni‐Bertollo, E. M., CASTILHO, R. M., & SQUARIZE, C. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105633 · Cited by 6
Köthe, A., Lomax, A., Giovannelli, A. C., Safai, S., Bizzocchi, N., Roelofs, E., Even, A. J. G., Weber, D. C., & Fattori, G. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.09.021 · Cited by 6
Genetic Modulation of the GLUT1 Transporter Expression—Potential Relevance in Complex Diseases
Kulin, A., Kucsma, N., Bohár, B., Literáti-Nagy, B., Koranyi, L. I., Cserepes, J., Somogyi, A., Sarkadi, B., Szabó, E., & Várady, G. (2022) · Biology · doi:10.3390/biology11111669 · Cited by 7
Hypoxia-driven ncRNAs in breast cancer
Al-Zuaini, H. H., Zahid, K. R., Xiao, X., Raza, U., Huang, Q., & Zeng, T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1207253 · Cited by 7
Berrone, S., Giverso, C., Grappein, D., Preziosi, L., & Scialò, S. (2023) · Computers & Mathematics with Applications · doi:10.1016/j.camwa.2023.09.046 · Cited by 6
An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma
Zhang, T., Gu, Z., Ni, R., Wang, X., Jiang, Q., & Tao, R. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812361 · Cited by 6
Bioassembly of hemoglobin-loaded photopolymerizable spheroids alleviates hypoxia-induced cell death
Norberg, A. E., Bakırcı, E., Lim, K. S., Dalton, P. D., Woodfield, T. B. F., & Lindberg, G. C. J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad2a7d · Cited by 6
Waskowska, A., Lisowska, K. A., Daca, A., Henc, I., Brandberg, F., Mazurek, P., Brzustewicz, E., Witkowski, J. M., & Bryl, E. (2017) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2017.0006 · Cited by 6
Miyata, S., Tanabe, S., Isozaki, T., Xu, Y., & Suzuki, T. (2018) · Photochemical & Photobiological Sciences · doi:10.1039/c8pp00240a · Cited by 7
Bowler, E., & Ladomery, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9463-2_10 · Cited by 8
Piasecki, P., Majewska, A., Narloch, J., Maciak, M., Brodaczewska, K. K., Kuć, M., Waś, H., Wierzbicki, M., Brzozowski, K., Zięcina, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84000-7 · Cited by 6
Chan, C.-C., & Hsiao, Y.-Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040286 · Cited by 6
Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells
Bhattacharya, B., Huang, D. Q., Low, S. H. H., Tan, G. H., Han, M. J., Singh, S. S., Tang, B., Chang, S. C., Lim, J. S. Y., Omar, M. F. M., et al. (2021) · Oncotarget · doi:10.18632/oncotarget.27910 · Cited by 6
Mo, T., Brandal, S. H. B., Köhn‐Luque, A., Engebraaten, O., Kristensen, V. N., Fleischer, T., Hompland, T., & Seierstad, T. (2022) · Cancers · doi:10.3390/cancers14051326 · Cited by 6
Combining Mechanisms of Growth Arrest in Solid Tumours: A Mathematical Investigation
Colson, C., Byrne, H. M., & Maini, P. K. (2022) · Bulletin of Mathematical Biology · doi:10.1007/s11538-022-01034-2 · Cited by 6
Dhyani, V., Kumar, S., Manne, S. R., Kaur, I., Jana, S., Russell, S. M., Sarkar, R., & Giri, L. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00807 · Cited by 6
Rado, M., & Fisher, D. (2022) · Cells · doi:10.3390/cells11071197 · Cited by 5
Impact of Hypoxia on Radiation-Based Therapies for Liver Cancer
Villalobos, A., Lee, J. Y. H., Westergaard, S. A., & Kokabi, N. (2024) · Cancers · doi:10.3390/cancers16050876 · Cited by 5
Zhou, T., Li, Z., Huang, W., Zhou, E., Jiang, Y., Bai, Y., Chen, X., Lu, W., Xu, C., Xu, C., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00968-9 · Cited by 5
Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
Pontón, I., & Sánchez‐García, D. (2025) · Nanomaterials · doi:10.3390/nano15151139 · Cited by 6
Unlocking the potential of extracellular vesicles: one stimulus away from clinical implementation
Silva, R. M., Azevedo, A. M., Bonifácio, V. D. B., Fernandez-Becerra, C., & Pinto, S. N. (2025) · Biomaterials Science · doi:10.1039/d5bm01091h · Cited by 7
Cutibacterium acnes: An Emerging Prostate Cancer Pathogen
Brajdic, L., Reed, E., Pearson, H. B., & Brown, H. L. (2025) · Biology · doi:10.3390/biology15010030 · Cited by 5
Debruyne, C., Hodge, L., Hokamp, K., Ershova, A. S., Kröger, C., & Salcedo, S. P. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013265 · Cited by 5
Agent-based modeling of cellular dynamics in adoptive cell therapy
Wang, Y., Casarin, S., Daher, M., Mohanty, V., Dede, M., Shanley, M., Dondossola, E., Posta, L. L., Başar, R., Rezvani, K., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09653-4 · Cited by 5
Conductive Hydrogels for Exogenous Sensing and Cell Fate Control
Akbar, T. F., Jimenez-Rodriguez, C. A., Biktimirova, R., Hermes, I., Kurth, T., Pham, M. D., Tsurkan, M. V., Friedrichs, J., Morgan, F. L. C., Kleemann, H., et al. (2026) · Advanced Materials · doi:10.1002/adma.72866 · Cited by 5
Puthusseri, S. P., Ravivarma, S., Johny, M., & Vengellur, A. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01187-x · Cited by 5
Cui, B., Wen, M., Zhang, C., Zheng, Y., & Jia, Z. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202532131 · Cited by 5
Wishart, G., Gupta, P., Nisbet, A., Velliou, E. G., & Schettino, G. (2022) · British Journal of Radiology · doi:10.1259/bjr.20220832 · Cited by 5
Anaerobic growth and drug susceptibility of versatile fungal pathogen Scedosporium apiospermum
Yadav, K. K., Nimonkar, Y. S., Green, S. J., Dewala, S., Dhanorkar, M. N., Sharma, R. K., Rale, V. R., & Prakash, O. (2023) · iScience · doi:10.1016/j.isci.2023.108304 · Cited by 7
Litvinov, I. K., Belyaeva, T. N., Salova, A. V., Aksenov, N., Chelushkin, P. S., Solomatina, A. I., Tunik, S. P., & Корнилова, Е. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115606 · Cited by 5
LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis
Li, S.-N., Li, M., Guo, W., Zhang, L., Ding, Y., & Wu, X. (2023) · Gene · doi:10.1016/j.gene.2023.148033 · Cited by 5
Tang, X., Zheng, N., Lin, Q., You, Y., Gong, Z., Zhuang, Y., Wu, J., Wang, Y., Huang, H., Ke, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01922 · Cited by 6
Lim, A. H. W., Singhal, N., Bartholomeusz, D. L., Zobel, J., Naidu, J., Hsieh, W., Crouch, B., Wasan, H. S., Croagh, D. G., Nagrial, A. M., et al. (2024) · iGIE · doi:10.1016/j.igie.2024.06.005 · Cited by 5
Protocol for enriching, isolating, and testing drug susceptibility of facultative anaerobic fungi
Yadav, K. K., & Prakash, O. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103247 · Cited by 5
Karatkevich, D., Losmanová, T., Zens, P., Deng, H., Dubey, C., Zhang, T., Casty, C., Gao, Y., Neppl, C., Berezowska, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69347-x · Cited by 5
Acute Three‐Dimensional Hypoxia Regulates Angiogenesis
Ntekoumes, D., Song, J., Liu, H., Amelung, C. D., Guan, Y., & Gerecht, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403860 · Cited by 7
Kehr, N. S. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ada240 · Cited by 6
Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells
Sun, L., Ma, B., Yang, F., Zou, H., Guo, Y., Wang, X., & Han, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125113 · Cited by 5
3D Bioprinted Multidrug Resistance (MDR)-Dependent Tumor Spheroids
Hong, M., Hong, S., & Song, J. M. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c19291 · Cited by 5
Rastegar, G., Salman, M. M., & Sirsi, S. R. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125521 · Cited by 5
Self-oxygenating GMZ@HA nanocarriers enhance doxorubicin cytotoxicity in hypoxic breast cancer
Khoshsokhan, F., & Meshkini, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107117 · Cited by 5
Functional Roles and Mechanistic Insights of YEATS Domain Proteins in Digestive System Tumors
Chang, F., Yang, Y., Li, X., Dong, H., & Liu, K. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09117-5 · Cited by 5
Role of Reactive Species in Destructions
Arnhold, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816388-7.00002-4 · Cited by 5
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study
Yan, V. C., Yang, K. L., Ballato, E., Khadka, S., Shrestha, P., Arthur, K., Georgiou, D. K., Washington, M., Tran, T. T., Poral, A. H., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00203 · Cited by 5
The role of circadian and redox rhythms in cancer hypoxia
Omer, S., Karunagaran, D., & Suraishkumar, G. K. (2021) · Advances in Redox Research · doi:10.1016/j.arres.2021.100018 · Cited by 6
Sheidaei, Z., Akbarzadeh, P., Nguyen, N., & Kashaninejad, N. (2022) · Biomedical Microdevices · doi:10.1007/s10544-022-00615-1 · Cited by 5
Gamal‐Eldeen, A. M., Raafat, B. M., Alrehaili, A. A., El‐Daly, S. M., Hawsawi, N. M., Banjer, H. J., Raafat, E. M., & Almehmadi, M. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.854780 · Cited by 7
Agnes, M., Mazza, A., Kalydi, E., Béni, S., Malanga, M., & Manet, I. G. J. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202300511 · Cited by 5
Biological characterization of breast cancer spheroid formed by fast fabrication method
Iijima, Y., Uenaka, N., Morimoto, M., Sato, D., Hirose, S., Sakitani, N., Shinohara, M., Funamoto, K., Hayase, G., & Yoshino, D. (2024) · In vitro models · doi:10.1007/s44164-024-00066-3 · Cited by 6
Kehr, N. S. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202400181 · Cited by 6
Guo, M., Sun, Y., Wang, X., Wang, Z., Yuan, X., Chen, X., Yuan, X., & Wang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910486 · Cited by 5
Ultra‑high dose rate (FLASH) treatment: A novel radiotherapy modality (Review)
Huang, J., Cheng, J., Shi, B., Du, X., Tang, S., Lin, B., Mo, J., Yan, F., Luo, S., & Yang, H. (2025) · Molecular and Clinical Oncology · doi:10.3892/mco.2025.2818 · Cited by 5
Lu, Y., Hua, Y., Wang, B., Tian, Q., Zhong, F., Theophanous, A., Tahir, S., Lee, P., & Sigal, I. A. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100725 · Cited by 5
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment
Espín, R., Medina‐Jover, F., Sigüenza-Andrade, J., Farran-Matas, S., Mateo, F., Figueras, A., Sanz, R. T., Vicent, G. P., Shabbir, A., Ruiz-Auladell, L., et al. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf007 · Cited by 7
Chan, C.-C., Chen, G. T. Y., Hsueh, K.-L., & Hsiao, Y.-Y. (2022) · Cancers · doi:10.3390/cancers14051262 · Cited by 5
Deng, J., & Wen, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.824799 · Cited by 5
Seco, J. C., King, C. C., Camazzola, G., Jansen, J., Tirinato, L., Marafioti, M. G., Hanley, R., Pagliari, F., & Beckman, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095077 · Cited by 5
Microfluidic oxygen tolerability screening of nanocarriers for triplet fusion photon upconversion
Isokuortti, J., Kiiski, I. M. A., Sikanen, T. M., Durandin, N. A., & Laaksonen, T. (2022) · Journal of Materials Chemistry C · doi:10.1039/d2tc00156j · Cited by 5
Du, T., Liu, R., Zhang, Q., Luo, H., Chen, Y., Tan, M., Wang, Q., Wu, X., Liu, Z., Sun, S., et al. (2022) · European journal of medical research · doi:10.1186/s40001-022-00942-2 · Cited by 5
Rashed, F. B., Kate, W. D., Fanta, M., Wiebe, L. I., Kumar, P., & Weinfeld, M. (2023) · Antioxidants · doi:10.3390/antiox12020389 · Cited by 5
Electrochemical mapping of oxygenation in the three-dimensional multicellular tumour hemi-spheroid
Sheth, D., & Gratzl, M. (2019) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2018.0647 · Cited by 5
Bioreducible Pro-drug Inhibitors of EnolasePreprint
Yan, V. C., Yang, K., Ballato, E., Arthur, K., Georgiou, D., & Müller, F. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12033303.v1 · Cited by 5
UBE2V1 Promotes Hepatocellular Carcinoma Progression by Forming a Positive Feedback Loop with HIF-1α
Yuan, Z., Hu, S., Zhu, Q., Fang, Y., Liu, X., Li, S., Hu, X., Tu, K., Xu, Q., Huang, D., et al. (2025) · Research · doi:10.34133/research.1041 · Cited by 4
Integrated Luminescent Lifetime System for Continuous Oxygen Monitoring
Lopez, P. G. L., Tsiamis, A., & Mitra, S. (2024) · IEEE Sensors Applications Symposium (SAS) · doi:10.1109/sas60918.2024.10636517 · Cited by 4
Alves, J. L., Reis, P. M., Quinta-Ferreira, R. M., Quinta-Ferreira, M. E., & Matias, C. M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105882 · Cited by 4
Benoit, A., Lequeux, A., Harter, P., Berchem, G., & Janji, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-77628-8 · Cited by 4
Metadata
- Authors
- McKeown, S. R.
- Affiliations
- University of Ulster (GB)
- Corresponding author
- McKeown, S R
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 87
- Issue
- 1035
- Pages
- 20130676
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- PMC
- PMC4064601
- OpenAlex
- W2018722597
- Cited by
- 1,050
- References
- 126
- Citations by year
- 2026: 84 · 2025: 122 · 2024: 129 · 2023: 139 · 2022: 137 · 2021: 152 · 2020: 107 · 2019: 68 · 2018: 56 · 2017: 33 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor hypoxia, tumor oxygenation, normoxia, treatment response, prostate cancer, pancreatic cancer, malignant progression
- MeSH terms
- Animals, Hypoxia, Humans, Male, Neoplasms, Oxygen, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review